Mike Kelliher

CIK: 0001987188

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)12 (66.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ARDX

ARDELYX, INC.

Officer

CAPR

CAPRICOR THERAPEUTICS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (18 total)

ARDX
ARDELYX, INC.
Aug 21, 2026
Sale(S)
Direct
2K shares at avg. $3.86$8K
ARDX
ARDELYX, INC.
Aug 21, 2026
Sale(S)
Direct
3.1K shares at avg. $3.86$12K
ARDX
ARDELYX, INC.
Aug 21, 2026
Sale(S)
Direct
2.7K shares at avg. $3.86$10K
ARDX
ARDELYX, INC.
May 21, 2026
Sale(S)
Direct
2.9K shares at avg. $6.27$18K
ARDX
ARDELYX, INC.
May 21, 2026
Sale(S)
Direct
1.9K shares at avg. $6.27$12K
ARDX
ARDELYX, INC.
May 21, 2026
Sale(S)
Direct
2.5K shares at avg. $6.27$16K
ARDX
ARDELYX, INC.
Feb 20, 2026
Sale(S)
Direct
2 shares at avg. $5.71$11.41
ARDX
ARDELYX, INC.
Feb 20, 2026
Sale(S)
Direct
8.4K shares at avg. $5.87$49K
ARDX
ARDELYX, INC.
Feb 20, 2026
Sale(S)
Direct
1.2K shares at avg. $5.71$7K
ARDX
ARDELYX, INC.
Jan 23, 2026
Award(A)
Direct
103.1K shares-
CAPR
CAPRICOR THERAPEUTICS, INC.
Jan 5, 2026
Award(A)
Stock Option (Right to Buy)
Direct
15.5K shares-
ARDX
ARDELYX, INC.
Nov 21, 2025
Sale(S)
Direct
5.6K shares at avg. $5.54$31K
ARDX
ARDELYX, INC.
Aug 21, 2025
Sale(S)
Direct
5.4K shares at avg. $5.93$32K
ARDX
ARDELYX, INC.
May 20, 2025
Sale(S)
Direct
14.5K shares at avg. $4.08$59K
ARDX
ARDELYX, INC.
Feb 25, 2025
Award(A)
Direct
136.7K shares-
CAPR
CAPRICOR THERAPEUTICS, INC.
Jan 2, 2025
Award(A)
Stock Option (Right to Buy)
Direct
11.9K shares-
CAPR
CAPRICOR THERAPEUTICS, INC.
Jan 2, 2025
Award(A)
Stock Option (Right to Buy)
Direct
1.4K shares-
CAPR
CAPRICOR THERAPEUTICS, INC.
Jan 2, 2025
Award(A)
Stock Option (Right to Buy)
Direct
5.8K shares-

		Type	Shares	Price		Ownership
Aug 21, 2026	ARDX ARDELYX, INC.	Sale(S)	2,002	$3.86	$7,722	Direct
Aug 21, 2026	ARDX ARDELYX, INC.	Sale(S)	3,104	$3.86	$11,972	Direct
Aug 21, 2026	ARDX ARDELYX, INC.	Sale(S)	2,652	$3.86	$10,228	Direct
May 21, 2026	ARDX ARDELYX, INC.	Sale(S)	2,900	$6.27	$18,176	Direct
May 21, 2026	ARDX ARDELYX, INC.	Sale(S)	1,870	$6.27	$11,720	Direct
May 21, 2026	ARDX ARDELYX, INC.	Sale(S)	2,478	$6.27	$15,531	Direct
Feb 20, 2026	ARDX ARDELYX, INC.	Sale(S)	2	$5.71	$11	Direct
Feb 20, 2026	ARDX ARDELYX, INC.	Sale(S)	8,434	$5.87	$49,465	Direct
Feb 20, 2026	ARDX ARDELYX, INC.	Sale(S)	1,159	$5.71	$6,622	Direct
Jan 23, 2026	ARDX ARDELYX, INC.	Award(A)	103,080	-	$0	Direct
Jan 5, 2026	CAPR CAPRICOR THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	15,500	-	-	Direct
Nov 21, 2025	ARDX ARDELYX, INC.	Sale(S)	5,560	$5.54	$30,785	Direct
Aug 21, 2025	ARDX ARDELYX, INC.	Sale(S)	5,417	$5.93	$32,132	Direct
May 20, 2025	ARDX ARDELYX, INC.	Sale(S)	14,522	$4.08	$59,270	Direct
Feb 25, 2025	ARDX ARDELYX, INC.	Award(A)	136,680	-	-	Direct
Jan 2, 2025	CAPR CAPRICOR THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	11,940	-	-	Direct
Jan 2, 2025	CAPR CAPRICOR THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	1,440	-	-	Direct
Jan 2, 2025	CAPR CAPRICOR THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	5,750	-	-	Direct

1-18 of 18 transactions

About Kelliher Mike

Kelliher Mike (SEC CIK 0001987188) files insider reports with the SEC as Chief Business Officer of ARDELYX, INC. (ARDX) and Director of CAPRICOR THERAPEUTICS, INC. (CAPR).

Signal8 holds 10 ownership filings by Kelliher Mike, all Form 4s, filed between Jan 6, 2025 and Aug 25, 2026. Those filings report 18 transactions, from Jan 2, 2025 to Aug 21, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kelliher Mike's filings is in WALTHAM, MA.

Recent filings by Kelliher Mike

Aug 21, 2026: Open-market sales of ARDX shares (3 lines, Form 4, code S).
May 21, 2026: Open-market sales of ARDX shares (3 lines, Form 4, code S).
Feb 20, 2026: Open-market sales of ARDX shares (3 lines, Form 4, code S).
Jan 23, 2026: Grant or award of ARDX shares (Form 4, code A).
Jan 5, 2026: Grant or award of CAPR derivative securities (Form 4, code A).

Other insiders filing for ARDELYX, INC. (ARDX)

Hohenleitner Susan, Chief Financial Officer
Reilly Joseph James
Bishop John E
Brady James Parker, Chief Human Resources Officer
Foster Eric Duane, Chief Commercial Officer
Williams Laura A, Chief Patient Officer

How to read Form 4 transaction codes